DE602008005857D1 - Neue antimalaria-impfstoffzusammensetzungen und anwendungen davon - Google Patents

Neue antimalaria-impfstoffzusammensetzungen und anwendungen davon

Info

Publication number
DE602008005857D1
DE602008005857D1 DE602008005857T DE602008005857T DE602008005857D1 DE 602008005857 D1 DE602008005857 D1 DE 602008005857D1 DE 602008005857 T DE602008005857 T DE 602008005857T DE 602008005857 T DE602008005857 T DE 602008005857T DE 602008005857 D1 DE602008005857 D1 DE 602008005857D1
Authority
DE
Germany
Prior art keywords
polypeptide
applications
new
transformed
vaccine compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602008005857T
Other languages
English (en)
Inventor
Stanislas Tomavo
Steven Graham Ball
Hulst Christophe D
David Dauvillee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Universite de Lille 1 Sciences et Technologies
Original Assignee
Centre National de la Recherche Scientifique CNRS
Universite de Lille 1 Sciences et Technologies
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS, Universite de Lille 1 Sciences et Technologies filed Critical Centre National de la Recherche Scientifique CNRS
Publication of DE602008005857D1 publication Critical patent/DE602008005857D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A61K39/015—Hemosporidia antigens, e.g. Plasmodium antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1048—Glycosyltransferases (2.4)
    • C12N9/1051—Hexosyltransferases (2.4.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE602008005857T 2007-01-23 2008-01-23 Neue antimalaria-impfstoffzusammensetzungen und anwendungen davon Active DE602008005857D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0752837A FR2911608B1 (fr) 2007-01-23 2007-01-23 Nouvelles compositions vaccinales anti paludique et ses utilisations.
PCT/EP2008/050758 WO2008090174A1 (fr) 2007-01-23 2008-01-23 Nouvelles compositions vaccinales anti paludique et ses utilisations

Publications (1)

Publication Number Publication Date
DE602008005857D1 true DE602008005857D1 (de) 2011-05-12

Family

ID=38106252

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602008005857T Active DE602008005857D1 (de) 2007-01-23 2008-01-23 Neue antimalaria-impfstoffzusammensetzungen und anwendungen davon

Country Status (7)

Country Link
US (1) US20100199391A1 (de)
EP (1) EP2121736B1 (de)
AT (1) ATE503765T1 (de)
DE (1) DE602008005857D1 (de)
ES (1) ES2363923T3 (de)
FR (1) FR2911608B1 (de)
WO (1) WO2008090174A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0410562B8 (pt) 2003-05-22 2021-05-25 Fralunhofer Usa Inc proteína de veículo e seu método de produção em uma planta, ácido nucleico isolado, vetor de expressão e célula hospedeira
WO2010037063A2 (en) * 2008-09-28 2010-04-01 Fraunhofer Usa, Inc. Plasmodium vaccines, antigens, compositions and methods
EP2223937A1 (de) * 2009-02-27 2010-09-01 Institut Pasteur Polypeptide zur Vorbeugung oder Behandlung von Malaria
EP2483307A1 (de) 2009-09-29 2012-08-08 Fraunhofer USA, Inc. Influenza-hämagglutinin-antikörper, zusammensetzungen daraus und zugehörige verfahren
CN114462079A (zh) * 2012-08-22 2022-05-10 元平台公司 用于多照片馈送故事的系统和方法
CN103965320A (zh) * 2013-01-29 2014-08-06 苏州偲聚生物材料有限公司 多肽、包含该多肽的检测器件和检测试剂盒
US9803211B2 (en) 2013-06-14 2017-10-31 J.R. Simplot Company Protein production in transgenic potato plants having suppressed expression of patatin and CD4B

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU730427B2 (en) * 1996-09-30 2001-03-08 Exseed Genetics L.L.C. Encapsulation of polypeptides within the starch matrix
FR2793806B1 (fr) * 1999-05-21 2003-04-25 Centre Nat Rech Scient Grains d'amidon contenant un polypeptide recombinant d'interet, leur procede d'obtention, et leurs utilisations
US7037681B2 (en) * 2000-02-08 2006-05-02 University Of Hawaii Plasmodium falciparum merozoite surface protein-1 malaria produced in transgenic plants
EP1473307A1 (de) * 2003-05-02 2004-11-03 Coöperatieve Verkoop- en Productievereniging, van Aardappelmeel en Derivaten AVEBE B.A. Methode zur Veränderung der Grösse und/oder Morphologie von Stärkekörnern

Also Published As

Publication number Publication date
WO2008090174A1 (fr) 2008-07-31
EP2121736B1 (de) 2011-03-30
ATE503765T1 (de) 2011-04-15
US20100199391A1 (en) 2010-08-05
FR2911608B1 (fr) 2009-04-03
FR2911608A1 (fr) 2008-07-25
ES2363923T3 (es) 2011-08-19
EP2121736A1 (de) 2009-11-25

Similar Documents

Publication Publication Date Title
DE602008005857D1 (de) Neue antimalaria-impfstoffzusammensetzungen und anwendungen davon
EA201291067A1 (ru) Гуманизированные антигенсвязывающие белки к миостатину
UA102867C2 (uk) Антитіла до cxcr4 та їх застосування у лікуванні раку
WO2008121615A3 (en) Antibody formulation
MA32980B1 (fr) Proteines de liaison a la myostatine
MX2012003939A (es) Fusiones y conjugados de farmaco.
UA113623C2 (uk) Моноклональне антитіло проти інгібітору шляху тканинного фактора (tfpi)
CL2012002095A1 (es) Polipéptido de unión biparatópico que comprende un primer dominio variable individual de inmunoglobulina (ig) que se une específicamente a un primer epítopo del péptido ß-amiloide (ßa) y un segundo dominio variable de ig que se une específicamente a un segundo epítopo del ßa, donde dichos epítopos del ßa no son idénticos; ácido nucleico que lo codifica; vector; célula hospedera; composición farmacéutica; método de preparación; y su uso en el tratamiento y/o prevención de depósitos del ßa
TN2011000534A1 (en) Anti cxcr4 antibodies for the treatment of hiv
TN2011000528A1 (en) Compositions and methods for antibodies targeting complement protein c3b
EA201400568A1 (ru) Альбуминсвязывающие антитела и их связывающие фрагменты
TW201129381A (en) Antibodies against human CSF-1R and uses thereof
SG178886A1 (en) Humanized anti-cdcp1 antibodies
BR112014006390A2 (pt) anticorpos, domínios variáveis e cadeias feitos especialmente para uso humano
BR112015008311A2 (pt) conjugados fármaco-proteína
EA201170357A1 (ru) Инженерные антитела к il-13: композиции, способы и применение
MX2010010776A (es) Fusiones y conjugados de farmaco.
EA201892184A1 (ru) Оптимизированные моноклональные антитела против ингибитора пути тканевого фактора
WO2010085700A3 (en) Treatment for obesity
BR112013002831A2 (pt) anticorpos direcionados contra a il-17
MX2011008763A (es) Peptidos foxm1 y vacunas que contienen los mismos.
WO2010011952A3 (en) Flip death effector domain derived peptides for inducing autophagy
JO3188B1 (ar) بروتينات رابطة لمولد الضد محددة لمكون p لنظير النشا بالمصل
EP2463303A3 (de) Monoklonale Antikörper zur Neutralisierung von Anthrax-Toxinen
BR112014023063A2 (pt) anticorpos que neutralizam rsv, mpv e pvm e usos dos mesmos